Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Chengdu Taihe Weiye Biotechnology

Request full access

Specialized in protecting amino acid and peptide drug intermediates

ChinaFounded 2013Biotech & Life Sciences

About Chengdu Taihe Weiye Biotechnology

Chengdu Taihe Weiye Biotechnology, commercially known as Tachem, operates as a specialized manufacturer of protected amino acids, non-natural amino acids, and peptide intermediates. The company was established in 2013 and is headquartered in Chengdu Tianfu International Biological City, China. Its legal representative and major shareholder is Qi Wei.

The firm's business model is centered on the research and development, production, and sale of high-purity chemical raw materials for the global pharmaceutical industry. Revenue is generated through the direct sale of its extensive product catalog, which includes over 1,000 types of protected and non-natural amino acids, as well as custom synthesis services for various impurities and product batches. Tachem serves a client base of large domestic and international pharmaceutical companies, having passed audits from over 40 such entities.

A significant milestone in the company's history was the establishment of a wholly-owned subsidiary, Gansu Tachem Co. Ltd., in 2020. This subsidiary houses the main production base in Lanzhou New Area, featuring standardized factories with an annual output capacity exceeding 200 tons. In 2022, the company further expanded its R&D capabilities by opening a new 3,000-square-meter experimental building in Chengdu, staffed by a research team of over 50 personnel. The company has secured significant funding, including an A+ round of nearly 300 million RMB in late 2023, attracting notable investors like CITIC Securities, Moutai Jinshi Fund, Qiming Venture Partners, and Hillhouse Capital.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
20.3/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Nov 2023 $41M $165M Qiming Venture Partners · GF Xinde Investment · GL Ventures · Jiayuan Venture Capital ↗
SERIES AOther financing Aug 2023 $28M $110M CICC · Sunmed Capital · Jiaxing Yuekai Jiahe Venture Capital · Hillhouse Capital ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Chengdu Taihe Weiye Biotechnology website traffic

Latest recorded traffic for Chengdu Taihe Weiye Biotechnology is 1K monthly website visits, up 56.3% over the last three months.

Latest monthly visits1K 3-month web change+56.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Chengdu Taihe Weiye Biotechnology in its local ecosystem

Live from Dealroom

The Chengdu Taihe Weiye Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A12 investors entered at this stage

Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Chengdu Taihe Weiye Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Chengdu Taihe Weiye Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.